Caris Life Sciences, Inc. CAI
24.43 USD -1.14 (-4.46%)
At closeNov 11, 2026, 5:45 AM EST
24.70 +0.27 +1.11%
Pre-market · Nov 11, 5:45 AM ET
23.90 Day range 25.80
14.19 52-week range 36.50
- YTD
- -9.45%
- 1 year
- -1.49%
News
benzinga.com Piper Sandler Maintains Neutral on Caris Life Sciences, Raises Price Target to $25 Piper Sandler analyst David Westenberg maintains Caris Life Sciences (NASDAQ:CAI) with a Neutral and raises the price target from $22 to $25.
zacks.com BTSG vs. CAI: Which Stock Should Value Investors Buy Now? Investors looking for stocks in the Medical Services sector might want to consider either BrightSpring Health Services, Inc. (BTSG) or Caris Life Sciences,?Inc. (CAI). But which of these two…
benzinga.com Citigroup Maintains Buy on Caris Life Sciences, Raises Price Target to $36 Citigroup analyst Albert Hu maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $28 to $36.
benzinga.com TD Cowen Maintains Buy on Caris Life Sciences, Raises Price Target to $38 TD Cowen analyst Dan Brennan maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $36 to $38.
benzinga.com VIX Spikes 39% as AI Tech Rout Wipes Out $2.2 Trillion: Stock Market Today The AI sell-off deepens after the Democratic midterm sweep, sending the S&P 500 toward its worst day since April 2025 as Nvidia, AMD and Micron sank.
benzinga.com Zillow Posts Downbeat Q3 Results, Joins HubSpot, Snap And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session U.S. stock futures were mixed as Zillow and several companies fell sharply premarket after weak results and lowered sales guidance.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers ADMA Biologics (NASDAQ:ADMA) shares rose 19.6% to $12.53 during Thursday's pre-market session. The market value of their outstanding shares is at $2.3 billion. As per the news, the Q3…
seekingalpha.com Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript
marketbeat.com Caris Life Sciences Q3 Earnings Call Highlights Caris Life Sciences NASDAQ: CAI raised its full-year revenue outlook after third-quarter sales rose 27%, as growth in cancer-testing volumes accelerated for a second consecutive quarter. The company…
zacks.com Caris Life Sciences,?Inc. (CAI) Q3 Earnings and Revenues Top Estimates Caris Life Sciences,?Inc. (CAI) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.08 per share a year ago.
benzinga.com Caris Life Sciences Q3 2026 Earnings Call Transcript Caris Life Sciences (NASDAQ:CAI) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com Caris Life Sciences Raises FY2026 Sales Guidance from $1.030B-$1.040B to $1.040B-$1.050B vs $1.030B Est Caris Life Sciences (NASDAQ:CAI) raises FY2026 sales outlook from $1.030 billion-$1.040 billion to $1.040 billion-$1.050 billion vs $1.030 billion estimate.
benzinga.com Caris Life Sciences Q3 EPS $0.05 Beats $0.04 Estimate, Sales $275.358M Beat $255.363M Estimate Caris Life Sciences (NASDAQ:CAI) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 37.5 percent decrease over earnings of…
prnewswire.com Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over 358,000 total oncology tests Raises 2026 revenue…
benzinga.com BTIG Maintains Buy on Caris Life Sciences, Raises Price Target to $38 BTIG analyst Mark Massaro maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $33 to $38.
benzinga.com Canaccord Genuity Maintains Hold on Caris Life Sciences, Raises Price Target to $30 Canaccord Genuity analyst Kyle Mikson maintains Caris Life Sciences (NASDAQ:CAI) with a Hold and raises the price target from $22 to $30.- benzinga.com Truist Financial, Regions Financial And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures mixed; Truist slips after mixed results, while Telkom Indonesia, Loma Negra, Omeros and others fall premarket.
benzinga.com Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today The Nasdaq 100 fell 1% by midday Wednesday after September CPI topped forecasts, pushing Treasury yields and rate-hike bets higher.- benzinga.com TD Cowen Maintains Buy on Caris Life Sciences, Raises Price Target to $36 TD Cowen analyst Dan Brennan maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $30 to $36.